PYXS vs VICI · rev $2.8M vs P/E 9.3, rev $2.08B
Pyxis Oncology Inc (PYXS) versus VICI Properties Inc (VICI) — a side-by-side from cached financials, not a winner call.
Pyxis Oncology Inc (PYXS) is a biotechnology company listed on NASDAQ.
VICI Properties Inc (VICI) is a reit - diversified company listed on NYSE.
Latest reported PYXS revenue for 2025-09-30 was $2.8M. Net income was -$22.0M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. PYXS currently screens at market cap $109.6M.
Latest reported VICI revenue for 2026-06-30 was $2.08B. Net income was $1.40B. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
PYXS currently screens at market cap $109.6M. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
Not investment advice. Open the PYXS and VICI stock pages for the full models.
Not investment advice.